Cargando…
GnRH Antagonists with or without Add-Back Therapy: A New Alternative in the Management of Endometriosis?
To evaluate the effectiveness of a new class of medical drugs, namely oral gonadotropin-releasing hormone (GnRH) antagonists, in the management of premenopausal women with endometriosis-associated pelvic pain. We reviewed the most relevant papers (n = 27) on the efficacy of new medical alternatives...
Autores principales: | Donnez, Jacques, Dolmans, Marie-Madeleine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583814/ https://www.ncbi.nlm.nih.gov/pubmed/34768770 http://dx.doi.org/10.3390/ijms222111342 |
Ejemplares similares
-
Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
por: Donnez, Jacques, et al.
Publicado: (2021) -
Uterine Adenomyosis: From Disease Pathogenesis to a New Medical Approach Using GnRH Antagonists
por: Donnez, Jacques, et al.
Publicado: (2021) -
Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015) -
Gonadotropin-Releasing Hormone (GnRH)/GnRH Receptors and Their Role in the Treatment of Endometriosis
por: Resta, Christina, et al.
Publicado: (2023) -
Combination GnRH antagonists for endometriosis: Balancing efficacy with side effects
por: Whitaker, L.H.R., et al.
Publicado: (2022)